Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE(R)-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in ...

ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...
Business Wire

Immunomic Therapeutics Doses First Patient in its Phase 1 Clinical Trial of ITI-1001, a pDNA Vaccine for the Treatment of Glioblastoma Multiforme

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately held, clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, today announced ...
Indiatimes

NCVT MIS ITI Result 2022: 1st, 2nd-year marksheet released on ncvtmis.gov.in, direct link

The NCVT ITI Board has announced the NCVT MIS ITI Annual Semester Result 2022 on the official website - ncvtmis.gov.in. Candidates can check and download their ITI 1st, 2nd, 3rd, & 4th Semester Exam ...